Solara Active Pharma Sciences Appoints Mr. Ajit Manocha as Chief Information Officer
Solara Active Pharma Sciences Limited has appointed Mr. Ajit Manocha as its Chief Information Officer (CIO), effective August 10, 2026. The appointment makes him part of the company’s Senior Management Personnel (SMP).The decision was made by the Board of Directors following a review conducted by the Nomination and Remuneration Committee. Mr. Manocha joins the company with extensive experience in technology leadership within the Life Sciences sector.
Mr. Ajit Manocha is described as a global technology and Life Sciences transformation leader, bringing over 33 years of experience to Solara Active Pharma Sciences Limited. His expertise spans driving digital transformation across pharmaceuticals, CRDMOs, manufacturing, and other regulated industries.
Key details regarding the appointment are summarized below:
| Particular | Details |
|---|---|
| Name | Mr. Ajit Manocha |
| Role | Chief Information Officer (CIO) / Senior Managerial Personnel (SMP) |
| Effective Date | August 10, 2026 |
| Profile Highlights | Mr. Manocha specializes in aligning technology strategy with business goals. His experience includes leading enterprise-wide SAP and S/4HANA transformations, implementing Industry 4.0, IoT, cybersecurity, and AI/ML/Generative AI initiatives. He possesses extensive experience working with Boards and senior leadership on technology strategy, cyber risk, and governance, ensuring protection of intellectual property and data integrity in highly regulated environments. |
SOLARA Stock Price Movement
As of 2:16 PM, shares of Solara Active Pharma Sciences Limited are slipping by 0.12% in live trading, currently priced at ₹535.5 after shedding ₹0.65 from the previous close. The equity has seen a volume of 649,767 shares, stabilizing above today's low of ₹520.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.